Начало・Списък с акции・Pacira Pharmaceuticals Inc-DE

Pacira Pharmaceuticals Inc-DE

Затворен

СекторЗдравеопазване

27.59 3.41

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

26.19

Максимум

27.59

Ключови измерители
By Trading Economics
Приходи	1.3M 2.9M
Продажби	-19M 177M
P/E Средно за сектора	207.077 68.51
EPS	0.6
Марж на печалбата	1.644
Служители	825
EBITDA	5M 30M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+17.64% upside

Дивиденти
By Acuity
Следващи печалби	5.11.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-40M 1.1B
Предишно отваряне	24.18
Предишно затваряне	27.59

Настроения в новините

By Acuity

50%

175 / 340 Класиране в Healthcare

Pacira Pharmaceuticals Inc-DE Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.08.2026 г., 19:53 ч. UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

3.08.2026 г., 20:06 ч. UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

31.07.2026 г., 20:02 ч. UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

30.07.2026 г., 17:16 ч. UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

29.07.2026 г., 20:04 ч. UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

28.07.2026 г., 19:56 ч. UTC

Event

News

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

27.07.2026 г., 18:51 ч. UTC

Event

News

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

24.07.2026 г., 17:16 ч. UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

22.07.2026 г., 18:06 ч. UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

21.07.2026 г., 19:56 ч. UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

20.07.2026 г., 19:46 ч. UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.

Сравнение с други в отрасъла

Ценова промяна

Pacira Pharmaceuticals Inc-DE Прогноза

Ценова цел

By TipRanks

17.64% нагоре

12-месечна прогноза

Среден 31.67 USD 17.64%

Висок 38 USD

Нисък 25 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Pacira Pharmaceuticals Inc-DE през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

3 ratings

Купи

Задържане

Продай

Според 3 анализатори, дали борсови рейтинги на Pacira Pharmaceuticals Inc-DE през последните 3 месеца.

Настроение

By Acuity

175 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.